Stem Cells: Viable Option for CHF or Pipe Dream? (CME/CE)

(MedPage Today) -- By pooling all available results from trials of bone-marrow-derived stem cells (BMSCs) in patients with ischemic heart disease or congestive heart failure, a Cochrane review found slight evidence to suggest a benefit for stem-cell therapy in those populations.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news